95% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
ORIGINAL RESEARCH article
Front. Public Health
Sec. Public Mental Health
Volume 13 - 2025 | doi: 10.3389/fpubh.2025.1580771
This article is part of the Research Topic The Intersection of Psychology, Healthy Behaviors, and its Outcomes View all 79 articles
The changing trend and prediction of the burden of anxiety disorder in Chinese population from 2022 to 2035
Provisionally accepted- 1 Yunnan University of Traditional Chinese Medicine, Kunming, China
- 2 Zhejiang Chinese Medical University, Hangzhou, Zhejiang Province, China
- 3 Anhui University of Chinese Medicine, Hefei, Anhui Province, China
Objective: To analyze the disease burden of anxiety disorders globally, in middle SDI countries, and in China using GBD public database. Methods: Data on anxiety disorders were extracted from the GBD database, and GBDR_V2.36 was used for data visualization and plotting. Results: From 1990 to 2021, global anxiety disorder cases and prevalence rose steadily. In 2021, the 30–34 age group had the highest global cases (male:female≈3:7), while DALY rates peaked in 25–29-year-olds. Medium-SDI countries followed similar trends, with peak DALYs in the 20–24 age group. China saw declining prevalence/incidence but rising DALYs, with highest cases in 50–54-year-olds (male:female≈3:5) and DALY rates in 75–84-year-olds. Globally, medium-SDI countries, and China, incidence peaked in 10–14-year-olds. Projections suggest China’s anxiety disorder burden will surge through 2035. Conclusion: Globally and in middle SDI countries, prevalence, incidence, and DALY rates increased, with the 30–34 age group showing the highest case burden (women outnumbering men) and peak DALY rates in younger adults (25–29 globally, 20–24 in middle SDI). In contrast, China saw a decline in prevalence and incidence, with the burden peaking later (50–54 for cases, 75–84 for DALYs). Projections indicate rising anxiety disorder burden in China by 2035, necessitating region- and age-specific interventions.
Keywords: Anxiety, disease burden, Epidemiology, China, GBD
Received: 21 Feb 2025; Accepted: 18 Mar 2025.
Copyright: © 2025 fan, PAN, fang and zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Ciming PAN, Yunnan University of Traditional Chinese Medicine, Kunming, China
jida zhang, Zhejiang Chinese Medical University, Hangzhou, 310053, Zhejiang Province, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.